AAQ1 Stock Overview
Develops, manufactures, and markets trauma products for orthopedics. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
aap Implantate AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €1.37 |
| 52 Week High | €2.90 |
| 52 Week Low | €0.65 |
| Beta | -0.35 |
| 1 Month Change | -34.13% |
| 3 Month Change | 15.13% |
| 1 Year Change | 86.39% |
| 3 Year Change | -53.08% |
| 5 Year Change | -71.16% |
| Change since IPO | -98.66% |
Recent News & Updates
Recent updates
Shareholder Returns
| AAQ1 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 4.6% | -0.6% | -0.2% |
| 1Y | 86.4% | -8.4% | 7.0% |
Return vs Industry: AAQ1 exceeded the German Medical Equipment industry which returned -8.4% over the past year.
Return vs Market: AAQ1 exceeded the German Market which returned 7% over the past year.
Price Volatility
| AAQ1 volatility | |
|---|---|
| AAQ1 Average Weekly Movement | 23.2% |
| Medical Equipment Industry Average Movement | 6.6% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.7% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: AAQ1's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: AAQ1's weekly volatility has increased from 16% to 23% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1990 | 111 | Rubino Di Girolamo | www.aap.de |
aap Implantate AG develops, manufactures, and markets trauma products for orthopedics. It offers LOQTEQ, an anatomical plating system for fracture treatment of ankle joint, knee, elbow, wrist, and shoulder; and straight plates and cannulated screws. The company sells its products directly to hospitals, purchasing groups, and hospital groups in Germany through a network of distributors.
aap Implantate AG Fundamentals Summary
| AAQ1 fundamental statistics | |
|---|---|
| Market cap | €15.81m |
| Earnings (TTM) | -€2.31m |
| Revenue (TTM) | €11.96m |
1.3x
P/S Ratio-6.8x
P/E RatioIs AAQ1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AAQ1 income statement (TTM) | |
|---|---|
| Revenue | €11.96m |
| Cost of Revenue | €1.47m |
| Gross Profit | €10.49m |
| Other Expenses | €12.80m |
| Earnings | -€2.31m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.21 |
| Gross Margin | 87.72% |
| Net Profit Margin | -19.32% |
| Debt/Equity Ratio | 8.1% |
How did AAQ1 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/27 19:44 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2023/06/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
aap Implantate AG is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Percy Leung | DBS Bank Ltd |
| Michael Bissinger | Dz Bank Ag |
| Hans Bjorn Bostrom | Edison Investment Research |